Breast cancer
Results
Phase 2
This trial looked at LCL161 with paclitaxel for breast cancer that doesn’t have receptors for progesterone, oestrogen or HER2. This is called triple negative breast cancer.
Recruitment start: 28 March 2013
Recruitment end: 31 March 2014
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Peter Schmid
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
Novartis
Last reviewed: 01 Aug 2019
CRUK internal database number: 10178
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
